Radiopharm Theranostics Limited ADR (RADX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 18,856 | 23,739 | 12,182 |
| Receivables | 6,735 | 4,072 | 648 |
| Other current assets | 218 | 1,085 | 2,154 |
| TOTAL | $25,809 | $28,896 | $14,984 |
| Non-Current Assets | |||
| PPE Net | N/A | 37 | N/A |
| Investments And Advances | 0 | 26 | 26 |
| Intangibles | 0 | 31,273 | 0 |
| Other Non-Current Assets | 30,162 | 0 | 32,191 |
| TOTAL | $30,162 | $31,336 | $32,217 |
| Total Assets | $56,006 | $60,233 | $47,241 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 6,049 | 4,779 | 7,120 |
| Other current liabilities | 3,621 | 1,728 | 4,406 |
| TOTAL | $9,671 | $8,564 | $11,526 |
| Non-Current Liabilities | |||
| Deferred Revenues | N/A | 2,058 | N/A |
| Other Non-Current Liabilities | 18,571 | 17,788 | 17,777 |
| TOTAL | $18,571 | $17,788 | $17,777 |
| Total Liabilities | $28,242 | $26,352 | $29,303 |
| Shareholders' Equity | |||
| Common Shares | 114,339 | 109,636 | 66,027 |
| Retained earnings | -94,377 | -83,252 | -73,016 |
| Other shareholders' equity | 7,802 | 7,497 | 24,927 |
| TOTAL | $27,764 | $33,880 | $17,938 |
| Total Liabilities And Equity | $56,006 | $60,233 | $47,241 |